Navigation Links
Massachusetts State Court Hears Suit by Breastfeeding Mother on Medical Licensing Exam
Date:9/18/2007

PHILADELPHIA, Sept. 18 /PRNewswire/ -- Judge Patrick Brady heard arguments yesterday in the lawsuit brought in Superior Court in Norfolk, Massachusetts by a breastfeeding mother seeking extra break time during the U.S. Medical Licensing Examination (USMLE).

"Fairness to all examinees and the integrity of the exam remain the overriding concerns of the exam's sponsors," said Joseph F. Savage, Jr., lawyer for the National Board of Medical Examiners, which co-sponsors the exam and was named in the suit brought by Sophie Currier and her infant daughter. "Our position remains that the exam's sponsors have in no way violated Ms. Currier's legal rights and have, in fact, done everything they can to address Ms. Currier's needs, consistent with exam policies."

Dr. Ruth Hoppe, NBME spokesperson, added, "We can assure all examinees that we continually review our policies on break time during the exam. But the stakes for public safety are too high for us to make decisions on a one-by- one, ad hoc basis."

Existing USMLE policy allows accommodations such as more testing or break time only for examinees with physical or mental impairments that substantially limit them in a major life activity, as set out in the Americans for Disabilities Act (ADA). As shown in her court filings, Ms. Currier had been granted two days, rather than the one day usually available, to take her exam because she has dyslexia and Attention Deficit Hyperactivity Disorder.

Additional arrangements that the exam's sponsors have offered Ms. Currier include:

-- Privacy, within the constraints of exam security, in the room that she

receives on account of her ADA disability to permit her to pump milk

while taking the test and on break time.

-- Permission to bring food and drink into the testing room so she could

eat and drink at any time during her test and/or break time.

-- Permission to bring multiple, assembled pumps to eliminate
'/>"/>

SOURCE National Board of Medical Examiners
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Fatal Case of Meningitis Detected In Massachusetts
2. Massachusetts Governor To Sign Health Coverage Bill
3. Massachusetts To Offer Free Cervical Cancer Vaccine
4. Massachusetts Leads The Way In Health Reforms
5. Health Insurance For Almost Everyone In Massachusetts
6. Whooping Cough Spreads from a Massachusetts Hospital
7. All Babies in Massachusetts Should Be Screened for Life-Threatening Disorders
8. Eastern Equine Encephalitis Spreading Its Tentacles in Massachusetts
9. Cancer Doctors Okays Controversial Prostate Therapy
10. More Accurate "PROSTATE CANCER" Test can save Unnecessary Biopsies
11. Scientists plan human cloning clinic in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)...t. 6 /PRNewswire/ -- Developed in collaboration wi...ades, CA is introducing,Revolutionary Breast Surfa...c Surgery office of Dr. Steve Laverson this week i...he first of its kind, and is based on,breakthrough...with,innovative proprietary software. The XS-300(T...
(Date:10/6/2008)...ct. 6 /PRNewswire/ -- The organizers of Informex a...e on Global Sourcing for the,Pharmaceutical Indust...inceton Marriott in New Jersey USA., The conferen... the,Global Sourcing Council, and boasts an unpara...e likes of Johnson & Johnson, Bristol Myers Squibb...
(Date:10/6/2008)... LegalView recently posted detailed inform...he potentially serious side effects caused by the ... the drug,s potential side effects are the develop... for young adult and child patients. , ...- LegalView, the number one resource for everythin...
(Date:10/6/2008)... Hospital Ship Serving in West Africa Rece...Garden Valley, Texas October 6, 2008 -- www.seamob...l provider of communications services to remote lo...s to the FoxNews channel via satellite to Mercy Sh...ica Mercy. The Africa Mercy is the world,s larges...
Breaking Medicine News(10 mins):Health News:Plan Your Breasts in 3-D 2Health News:Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 3Health News:Seamobile Provides Foxnews To Mercy Ships 2Health News:Seamobile Provides Foxnews To Mercy Ships 3
...earchers at Karolinska Institutet in Sweden have s...deployed as a vaccination agent in future// to sto...h is so far based on animal experiments, appears i...ne. Researchers at KI and Leiden University Medica...
...d flu and the spread of it as a pandemic illness h...es. Hence to prevent close contact among people// ... they have announced the closure of the schools, c...orts events and concerts. But the US research tea...
...hicken festival has been planned in Jharkhand impr...d due to the bird flu scare//. A variety of mouth-...The dishes to be served during the festival March ..., reshmi kebab, chilli chicken, chicken lollipop, ...
... Indian Medical Association has been angered over ...hic medicine and medical practitioners//. IMA nat...doctors across India against Ramdev for ‘misguidin...ioners and allopathic medicine. Ramdev had report...
Other Medicine News:Health News:US Thinks About The Alternative Methods To Combat Bird Flu 2
(Date:10/3/2008)... is the newest study site, PHILADELPHIA, Oct. 3 /...of Philadelphia today received a contract to manag...y. Children,s Hospital will manage local,participa...n County, New,Jersey. The study is funded by the N...cipate approximately 1,000 families in Burlington,...
(Date:10/2/2008)...ults of Rosetta Genomics, microRNA-based,Test, miR...rom non Squamous non Small Cell Lung Cancer, ...he miRview(TM) Technology First Approved for Clini...lexity Molecular Pathology Lab ...ecting to Launch miRview(TM) Squamous Later This ...
(Date:10/2/2008)...re-FirstCall/ - AEterna Zentaris Inc.,(NASDAQ: AE... focused on,endocrine therapy and oncology, today ...atient recruitment for its Phase 2 trial in ovaria...asing hormone (LHRH) agonist,linked to doxorubicin...t,recruitment was taken following recent first sta...
(Date:10/1/2008)...e sublingual lozenge) developed to be the first s... night when patients awaken and have diffi...ct. 1 /- Transcept Pharmaceuticals,I...pany, announced today,that it has submitted a New ...dministration (FDA) for its lead product candidate...
Breaking Medicine Technology:The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 3Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 4Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 5AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 3AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 4AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 5Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 2Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 3Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 4Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 5Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 6Majority of 2 4 Million U S Children With ADHD Not Diagnosed or Consistently Treated According to New Gold Standard Study by Cincinnati Childrens Re 389 1Majority of 2 4 Million U S Children With ADHD Not Diagnosed or Consistently Treated According to New Gold Standard Study by Cincinnati Childrens Re 389 2Majority of 2 4 Million U S Children With ADHD Not Diagnosed or Consistently Treated According to New Gold Standard Study by Cincinnati Childrens Re 389 3Majority of 2 4 Million U S Children With ADHD Not Diagnosed or Consistently Treated According to New Gold Standard Study by Cincinnati Childrens Re 389 4Teens who see more smoking in movies may have increased risk of becoming established smokers 384 1Teens who see more smoking in movies may have increased risk of becoming established smokers 384 29 25 of U S Kids Have ADHD 379 19 25 of U S Kids Have ADHD 379 29 25 of U S Kids Have ADHD 379 3Work Time Predicts Sleep Time 375 1Work Time Predicts Sleep Time 375 2
...Call/ -- CEL-SCI,CORPORATION announces that CEL-10...influenza antigen in combination with MAS-1, a,wat... were,presented on May 23, 2007 by Dr. Daniel Zimm... Immunology at CEL-SCI at the,American Society of ...ronto, Canada. , This new finding with CEL-1000 ma...
...e on Work Status and,Productivity, WASHINGTON, May...nted today at Digestive Disease Week(R) 2007 (DDW)...ive Ulcerative Colitis 1,& 2) show that subjec...olitis (UC) who had responded to REMICADE(R),(infl...ned,improvement in their clinical symptoms for up ...
Other Medicine Technology:CEL-SCI'S CEL-1000 Shown to Significantly Enhance Immune Response,Against Avian Flu Antigen in Animals 2Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 2Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 3Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 4Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 5Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 6Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 7Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 8Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 9
ArcticTemp Upright Freezer -20C. Quick, even freezing. Heavy duty compressor. Deep door racks. Front gated bottom shelf. Interior light. Locks One year warranty on unit and 5 year warranty on compres
Undercounter Freezer -25C. White. Front opening freezer. 4 cubic ft capacity. Reversible door. Three slide-out drawers. Extra thick CFC insulation. Front lock. Front indicator lights. Attractive tabl
...240 is a basic portable system for pH and temperat...ts can be obtained when used with a temperature pr...asy one- and two-point calibration with Auto-Find ...1.68, 4.00, 7.00, 10.01 and 12.45) and Auto-Read f...
...250 is a portable system for routine pH, mV (ORP),...ture compensated pH results can be obtained when u...ctrode. • Fast and easy one-, two- and three-...recognition for five buffers (pH 1.68, 4.00, 7.00,...
Medicine Products: